bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplemental Legends and Tables from Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma
Authors: Anderson Bradley W. , Suh Yun-Suhk , Choi Boram , Lee Hyuk-Joon , Yab Tracy C. , Taylor William R. , Dukek Brian A. , Berger Calise K. , Cao Xiaoming , Foote Patrick H. , Devens Mary E. , Boardman Lisa A. , Kisiel John B. , Mahoney Douglas W. , Slettedahl Seth W. , Allawi Hatim T. , Lidgard Graham P. , Smyrk Thomas C. , Yang Han-Kwang , Ahlquist David A.
Published: April 2023

Supplemental Table 1: Discrimination for gastric adenocarcinoma (GAC) from normal gastric mucosa by the top 22 methylated DNA marker candidates in Discovery and Technical Validation Sets. Supplemental Table 2: Function of Genes Containing Differentially Methylated Regions Identified as Targets for Candidate Markers Supplemental Table 3: Covariate Effects on Tissue Levels of Methylated DNA Marker Candidates (Data shown represent p-values).
Supplemental Table 1 from Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival
Authors: Subbiah Vivek , Lamhamedi-Cherradi Salah-Eddine , Cuglievan Branko , Menegaz Brian A. , Camacho Pamela , Huh Winston , Ramamoorthy Vandhana , Anderson Pete M. , Pollock Raphael E. , Lev Dina C. , Qiao Wei , McAleer Mary Frances , Benjamin Robert S. , Patel Shreyaskumar , Herzog Cynthia E. , Daw Najat C. , Feig Barry W. , Lazar Alexander J. , Hayes-Jordan Andrea , Ludwig Joseph A.
Published: April 2023

Univariate parameters & statistics assessed for all patients
Supplemental Figure S2 from Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival
Authors: Subbiah Vivek , Lamhamedi-Cherradi Salah-Eddine , Cuglievan Branko , Menegaz Brian A. , Camacho Pamela , Huh Winston , Ramamoorthy Vandhana , Anderson Pete M. , Pollock Raphael E. , Lev Dina C. , Qiao Wei , McAleer Mary Frances , Benjamin Robert S. , Patel Shreyaskumar , Herzog Cynthia E. , Daw Najat C. , Feig Barry W. , Lazar Alexander J. , Hayes-Jordan Andrea , Ludwig Joseph A.
Published: April 2023

. Subset analysis of the impact of CCS, HIPEC, and WART in patients with limited abdomen-only disease, which allows intra-abdominal lymphadenopathy but excludes patients harboring liver implants
Supplementary Figure from A C-X-C Chemokine Receptor Type 2–Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis
Authors: Zhou Zhijun , Xia Guanggai , Xiang Zhen , Liu Mingyang , Wei Zhewei , Yan Jie , Chen Wei , Zhu Jintao , Awasthi Niranjan , Sun Xiaotian , Fung Kar-Ming , He Yulong , Li Min , Zhang Changhua
Published: April 2023

The Supplementary Figure includes Supplementary Figure 1 to Supplementary Figure 7.
Figure S4 from Effect of Perioperative Opioids on Cancer-Relevant Circulating Parameters: Mu Opioid Receptor and Toll-Like Receptor 4 Activation Potential, and Proteolytic Profile
Authors: Xie Nan , Matigian Nicholas , Vithanage Tharindu , Gregory Kye , Nassar Zeyad D. , Cabot Peter J. , Shaw Paul N. , Kirkpatrick Carl M.J. , Cao Kim-Anh Lê , Sturgess David , Parat Marie-Odile
Published: April 2023

Relationship between cAMP measurements and morphine mouse administration, and in vitro morphine-spiked plasma concentration. Data was analysed with GraphPad Prism software (v. 7.00). A) Mice were treated with saline or morphine (1 or 10 mg/kg) and plasma samples were collected 10 min after intraperitoneal injection. cAMP production was determined by the AlphascreenTM assay. Graph shows morphine doses and cAMP production, for n=27 mice. B) 0.5 μL mouse plasma were spiked with indicated concentrations of morphine, and cAMP production by HEK-MOP cells was determined by the AlphascreenTM assay. Scatter plot shows in vitro morphine concentrations and cAMP production.
Figure S1 to S9 from Vitamin D Supplementation and Survival of Patients with Non–small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
Authors: Akiba Tadashi , Morikawa Toshiaki , Odaka Makoto , Nakada Takeo , Kamiya Noriki , Yamashita Makoto , Yabe Mitsuo , Inagaki Takuya , Asano Hisatoshi , Mori Shohei , Tsukamoto Yo , Urashima Mitsuyoshi
Published: April 2023

Figure S1. Relapse-free survival curves (A) and overall survival curves (B) of patients stratified by 25(OH)D equal to or greater than 30 ng/mL. Figure S2. Kaplan-Meier curves of patients restricted only to adenocarcinoma, or both early stages (IA - IIB) and adenocarcinoma. Figure S3. Relapse-free survival curves (A) and overall survival curves (B) of patients stratified by SNPs of FokI. Mean (SD) of 25(OH)D in each genotype are as follows; FokI CC, 19.9 (6.2) ng/ml; CT, 21.8 (6.6) ng/ml; TT 21.4 (7.9) ng/ml. Figure S4. Relapse-free survival curves (A) and overall survival curves (B) of patients stratified by SNPs of BsmI. Mean (SD) of 25(OH)D in each genotype are as follows: BsmI AA, 15 (-) ng/ml; AG, 20.2 (6.4) ng/ml; GG 21.7 (6.8) ng/ml. Figure S6. Relapse-free survival curves (A) and overall survival curves (B) of patients stratified by SNPs of ApaI. Mean (SD) of 25(OH)D in each genotype are as follows: ApaI GG, 21.2 (7.2) ng/ml; GT, 21.4 (6.3) ng/ml; TT, 21.5 (7.7) ng/ml. Figure S7. Relapse-free survival curves (A) and overall survival curves (B) of patients stratified by SNPs of TaqI. Mean (SD) of 25(OH)D in each genotype are as follows: TaqI TT, 21.7 (6.7) ng/ml; TG, 20.4 (6.9) ng/ml; GG, - (-) ng/ml. Figure S8. Relapse-free survival curves (A) and overall survival curves (B) of patients stratified by SNPs of DBP1. Mean (SD) of 25(OH)D in each genotype are as follows: DBP1 TT, 21.3 (7.0) ng/ml; TG, 20.8 (6.0) ng/ml; GG, 23.6 (7.9) ng/ml. Figure S9. Relapse-free survival curves (A) and overall survival curves (B) of patients stratified by SNPs of DBP2. Mean (SD) of 25(OH)D in each genotype are as follows: DBP2 CC, 22.7 (6.6) ng/ml; CA, 20.0 (6.3) ng/ml; AA, 12.8 (1.5) ng/ml.
Table S2 from Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer
Authors: Soumerai Tara E. , Donoghue Mark T.A. , Bandlamudi Chaitanya , Srinivasan Preethi , Chang Matthew T. , Zamarin Dmitriy , Cadoo Karen A. , Grisham Rachel N. , O'Cearbhaill Roisin E. , Tew William P. , Konner Jason A. , Hensley Martee L. , Makker Vicky , Sabbatini Paul , Spriggs David R. , Troso-Sandoval Tiffany A. , Charen Alexandra Snyder , Friedman Claire , Gorsky Mila , Schweber Sarah J. , Middha Sumit , Murali Rajmohan , Chiang Sarah , Park Kay J. , Soslow Robert A. , Ladanyi Marc , Li Bob T. , Mueller Jennifer , Weigelt Britta , Zehir Ahmet , Berger Michael F. , Abu-Rustum Nadeem R. , Aghajanian Carol , DeLair Deborah F. , Solit David B. , Taylor Barry S. , Hyman David M.
Published: April 2023

Recurrent cases in MSKCC vs. TCGA cohort
Figure S1 from The Role of Adding Somatostatin Analogues to Peptide Receptor Radionuclide Therapy as a Combination and Maintenance Therapy
Authors: Yordanova Anna , Wicharz Marcel M. , Mayer Karin , Brossart Peter , Gonzalez-Carmona Maria A. , Strassburg Christian P. , Fimmers Rolf , Essler Markus , Ahmadzadehfar Hojjat
Published: April 2023

Consort diagram of the study population. At the beginning of the analyses 421 patients, treated with peptide receptor radionuclide therapy (PRRT), were assessed. Patients who did not meet the inclusion criteria were excluded. These were mainly patients with pulmonary NET, NET with unknown primary, G3-tumors and patients with overall-follow up of < 6 months. Depending on the therapy protocol the study population was divided into two groups. Group 1 was patients, who underwent a peptide receptor radionuclide therapy (PRRT) as a monotherapy and received no maintenance therapy with SSA. In group 2, patients received a maintenance therapy with SSA after a monotherapy with PRRT or underwent a PRRT combined with SSA, followed by a maintenance therapy with SSA. A pre-treatment with SSA was allowed in both groups. Patients who could not be clearly classified into these groups were excluded.
Figure S5 from Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration
Authors: Liu Qiuli , Tong Dali , Liu Gaolei , Gao Jie , Wang Lin-ang , Xu Jing , Yang Xingxia , Xie Qiubo , Huang Yiqiang , Pang Jian , Wang Luofu , He Yong , Zhang Dianzheng , Ma Qiang , Lan Weihua , Jiang Jun
Published: April 2023

Supplementary Figure S5. The direct effects of metformin on prostate cancer cells. (A and B) PC-3 and DU145 cells were seeded in 96-well plates with 0.5Ã-105 cells per well in growth media with or without metformin (20mM). Cell viabilities were estimated by MTT every other day. (C and D) PC-3 and DU145 cells were seeded in 96-well plates with 0.5Ã-105 cells per well in growth media with different concentrations of metformin (0, 1, 5, 10, and 20 mM) and cell viabilities were estimated by MTT at 48 h. (E-H) PC-3 and DU145 cells were treated with different concentrations of metformin and the numbers of cells at different stages of the cycle were analyzed by ï¬,ow cytometry (E and F), or stained with PI and FITC-labelled Annexin V and subsequently underwent ï¬,ow cytometry analysis to determine the percentage of apoptotic cells (G and H).
Figure S2 from First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors
Authors: Tao Jessica J. , Cangemi Nicholas A. , Makker Vicky , Cadoo Karen A. , Liu Joyce F. , Rasco Drew W. , Navarro Willis H. , Haqq Christopher M. , Hyman David M.
Published: April 2023

Development of diffuse telangiectasias (highlighted by blue arrows) occurred on the upper chest, back, and face in a patient with ovarian granulosa cell tumor treated at the 0.75 mg/kg Q2W dose of STM 434.
Supplementary Data Table 5 from Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway Activation
Authors: Wang Victoria E. , Xue Jenny Y. , Frederick Dennie T. , Cao Yi , Lin Eva , Wilson Catherine , Urisman Anatoly , Carbone David P. , Flaherty Keith T. , Bernards Rene , Lito Piro , Settleman Jeff , McCormick Frank
Published: April 2023

Table S5 shows the raw counts from RNA sequencing of paired non-small cell lung cancer samples with BRAF mutations pre- and post-treatment using BRAF/MEK inhibitor combinations
Supplementary Figure 3 from Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non–Small-Cell Lung Cancer
Authors: Pailler Emma , Faugeroux Vincent , Oulhen Marianne , Mezquita Laura , Laporte Mélanie , Honoré Aurélie , Lecluse Yann , Queffelec Pauline , NgoCamus Maud , Nicotra Claudio , Remon Jordi , Lacroix Ludovic , Planchard David , Friboulet Luc , Besse Benjamin , Farace Françoise
Published: April 2023

Supplementary Figure 3
Supplementary Data Table 2 from Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway Activation
Authors: Wang Victoria E. , Xue Jenny Y. , Frederick Dennie T. , Cao Yi , Lin Eva , Wilson Catherine , Urisman Anatoly , Carbone David P. , Flaherty Keith T. , Bernards Rene , Lito Piro , Settleman Jeff , McCormick Frank
Published: April 2023

Table S2 shows mutations in A375 CobiR cells compared to the parental using exome sequencing
Figure S4 from TFEB Mediates Immune Evasion and Resistance to mTOR Inhibition of Renal Cell Carcinoma via Induction of PD-L1
Authors: Zhang Cai , Duan Yaqi , Xia Minghui , Dong Yuting , Chen Yufei , Zheng Lu , Chai Shuaishuai , Zhang Qian , Wei Zhengping , Liu Na , Wang Jing , Sun Chaoyang , Tang Zhaohui , Cheng Xiang , Wu Jie , Wang Guoping , Zheng Fang , Laurence Arian , Li Bing , Yang Xiang-Ping
Published: April 2023

mTOR inhibition and PD-L1 expression in lung and colon cancer cells
Supplementary Data from Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA
Authors: Kaseb Ahmed O. , Sánchez Nora S. , Sen Shiraj , Kelley Robin K. , Tan Benjamin , Bocobo Andrea G. , Lim Kian H. , Abdel-Wahab Reham , Uemura Marc , Pestana Roberto Carmagnani , Qiao Wei , Xiao Lianchun , Morris Jeffrey , Amin Hesham M. , Hassan Manal M. , Rashid Asif , Banks Kimberly C. , Lanman Richard B. , Talasaz AmirAli , Mills-Shaw Kenna R. , George Bhawana , Haque Abedul , Raghav Kanwal P.S. , Wolff Robert A. , Yao James C. , Meric-Bernstam Funda , Ikeda Sadakatsu , Kurzrock Razelle
Published: April 2023

Supplemental table 3
Supplementary Data from Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype
Authors: Takenaka Masataka , Köbel Martin , Garsed Dale W. , Fereday Sian , Pandey Ahwan , Etemadmoghadam Dariush , Hendley Joy , Kawabata Ayako , Noguchi Daito , Yanaihara Nozomu , Takahashi Hiroyuki , Kiyokawa Takako , Ikegami Masahiro , Takano Hirokuni , Isonishi Seiji , Ochiai Kazuhiko , Traficante Nadia , Gadipally Sreeja , Semple Timothy , Vassiliadis Dane , Amarasinghe Kausyalya , Li Jason , Mir Arnau Gisela , Okamoto Aikou , Friedlander Michael , Bowtell David D. L.
Published: April 2023

Supplementary Figures
Figure S1 from Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array
Authors: Li Jiuyi , Xue Yang , Wenger Anna , Sun Yingyu , Wang Zheng , Zhang Chuanbao , Zhang Yunqiu , Fekete Boglarka , Rydenhag Bertil , Jakola Asgeir Store , Jiang Tao , Carén Helena , Fan Xiaolong
Published: April 2023

Figure S1 shows the pearson correlation coefficients for the expression of all 44 classifier genes in 59 samples of the training set.
Supplementary Data from Treatment with Humanized Selective CD19CAR-T Cells Shows Efficacy in Highly Treated B-ALL Patients Who Have Relapsed after Receiving Murine-Based CD19CAR-T Therapies
Authors: Zhao Yu , Liu Zhongfeng , Wang Xuan , Wu Huantong , Zhang Jianping , Yang Junfang , Zhang Fayou , Liu Lining , Long Jiafu , Lu Peihua , Chen Zhiguo
Published: April 2023

Supplementary Figures and Tables
Supplementary Data from Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung Adenocarcinoma
Authors: Zhou Jian , Sanchez-Vega Francisco , Caso Raul , Tan Kay See , Brandt Whitney S. , Jones Gregory D. , Yan Shi , Adusumilli Prasad S. , Bott Matthew , Huang James , Isbell James M. , Sihag Smita , Molena Daniela , Rusch Valerie W. , Chatila Walid K. , Rekhtman Natasha , Yang Fan , Ladanyi Marc , Solit David B. , Berger Michael F. , Schultz Nikolaus , Jones David R.
Published: April 2023

Online supplement
Table S1 from Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer
Authors: Kraya Adam A. , Maxwell Kara N. , Wubbenhorst Bradley , Wenz Brandon M. , Pluta John , Rech Andrew J. , Dorfman Liza M. , Lunceford Nicole , Barrett Amanda , Mitra Nandita , Morrissette Jennifer J.D. , Feldman Michael , Nayak Anupma , Domchek Susan M. , Vonderheide Robert H. , Nathanson Katherine L.
Published: April 2023

Mutational and clinical characteristics of TCGA breast cancer data
Supplementary Data from OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL
Authors: Evans Kathryn , Duan JianXin , Pritchard Tara , Jones Connor D. , McDermott Lisa , Gu Zhaohui , Toscan Cara E. , El-Zein Narimanne , Mayoh Chelsea , Erickson Stephen W. , Guo Yuelong , Meng Fanying , Jung Donald , Rathi Komal S. , Roberts Kathryn G. , Mullighan Charles G. , Shia Chi-Sheng , Pearce Tillman , Teicher Beverly A. , Smith Malcolm A. , Lock Richard B.
Published: April 2023

This file contains Supplementary Methods, Supplementary Figures and Supplementary Tables
Supplementary Data from The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma
Authors: Kim Sun-Hee , Roszik Jason , Cho Sung-Nam , Ogata Dai , Milton Denái R. , Peng Weiyi , Menter David G. , Ekmekcioglu Suhendan , Grimm Elizabeth A.
Published: April 2023

Supplementary Table 1. Association between OS/RFS and expression group of mPGES1 and CD8 in stage III melanoma.
Supp. Table 1 from Expression of PD-1 by T Cells in Malignant Glioma Patients Reflects Exhaustion and Activation
Authors: Davidson Tom B. , Lee Alexander , Hsu Melody , Sedighim Shaina , Orpilla Joey , Treger Janet , Mastall Max , Roesch Saskia , Rapp Carmen , Galvez Mildred , Mochizuki Aaron , Antonios Joseph , Garcia Alejandro , Kotecha Nikesh , Bayless Nicholas , Nathanson David , Wang Anthony , Everson Richard , Yong William H. , Cloughesy Timothy F. , Liau Linda M. , Herold-Mende Christel , Prins Robert M.
Published: April 2023

Supplementary Table 1: Panel of CyTOF markers used in our study and how each marker was classified.
Supplementary Table S2 from Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT)
Authors: Okada Morihito , Kijima Takashi , Aoe Keisuke , Kato Terufumi , Fujimoto Nobukazu , Nakagawa Kazuhiko , Takeda Yuichiro , Hida Toyoaki , Kanai Kuninobu , Imamura Fumio , Oizumi Satoshi , Takahashi Toshiaki , Takenoyama Mitsuhiro , Tanaka Hiroshi , Hirano Jun , Namba Yoshinobu , Ohe Yuichiro
Published: April 2023

Criteria for discontinuation of nivolumab
Supplementary Data from Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer
Authors: Greally Megan , Chou Joanne F. , Chatila Walid K. , Margolis Matthew , Capanu Marinela , Hechtman Jaclyn F. , Tuvy Yaelle , Kundra Ritika , Daian Foysal , Ladanyi Marc , Kelsen David P. , Ilson David H. , Berger Michael F. , Tang Laura H. , Solit David B. , Diaz Luis A. , Schultz Nikolaus , Janjigian Yelena Y. , Ku Geoffrey Y.
Published: April 2023

PFS analysis by gene alteration occurring in 10% or more of MSS patients who received combination therapy
Figure S2 from Spatial Architecture and Arrangement of Tumor-Infiltrating Lymphocytes for Predicting Likelihood of Recurrence in Early-Stage Non–Small Cell Lung Cancer
Authors: Corredor Germán , Wang Xiangxue , Zhou Yu , Lu Cheng , Fu Pingfu , Syrigos Konstantinos , Rimm David L. , Yang Michael , Romero Eduardo , Schalper Kurt A. , Velcheti Vamsidhar , Madabhushi Anant
Published: April 2023

Figure S2. Kaplan-Meier plots for clinical characteristics of patients a) Sex, b) Tumor stage, c) T stage, and d) N stage using recurrence free survival as endpoint. Columns 1, 2, and 3 correspond to D1, D2, and D3, respectively.
Supplementary Data from Whole–Genome Sequencing of Childhood Cancer Survivors Treated with Cranial Radiation Therapy Identifies 5p15.33 Locus for Stroke: A Report from the St. Jude Lifetime Cohort Study
Authors: Sapkota Yadav , Cheung Yin Ting , Moon Wonjong , Shelton Kyla , Wilson Carmen L. , Wang Zhaoming , Mulrooney Daniel A. , Zhang Jinghui , Armstrong Gregory T. , Hudson Melissa M. , Robison Leslie L. , Krull Kevin R. , Yasui Yutaka
Published: April 2023

Supplementary Methods
Figure S1 from Class 1, 2, and 3 BRAF-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization
Authors: Schirripa Marta , Biason Paola , Lonardi Sara , Pella Nicoletta , Pino Maria Simona , Urbano Federica , Antoniotti Carlotta , Cremolini Chiara , Corallo Salvatore , Pietrantonio Filippo , Gelsomino Fabio , Cascinu Stefano , Orlandi Armando , Munari Giada , Malapelle Umberto , Saggio Serena , Fontanini Gabriella , Rugge Massimo , Mescoli Claudia , Lazzi Stefano , Reggiani Bonetti Luca , Lanza Giovanni , Dei Tos Angelo Paolo , De Maglio Giovanna , Martini Maurizio , Bergamo Francesca , Zagonel Vittorina , Loupakis Fotios , Fassan Matteo
Published: April 2023

Supplementary Figure S1
Supplementary Figure Legend from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
Authors: Del Papa Beatrice , Baldoni Stefano , Dorillo Erica , De Falco Filomena , Rompietti Chiara , Cecchini Debora , Cantelmi Maria Grazia , Sorcini Daniele , Nogarotto Manuel , Adamo Francesco Maria , Mezzasoma Federica , Silva Barcelos Estevão Carlos , Albi Elisa , Iacucci Ostini Roberta , Di Tommaso Ambra , Marra Andrea , Montanaro Guido , Martelli Maria Paola , Falzetti Franca , Di Ianni Mauro , Rosati Emanuela , Sportoletti Paolo
Published: April 2023

Supplementary Figure Legend
Table S3 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort
Authors: Dihge Looket , Vallon-Christersson Johan , Hegardt Cecilia , Saal Lao H. , Häkkinen Jari , Larsson Christer , Ehinger Anna , Loman Niklas , Malmberg Martin , Bendahl Pär-Ola , Borg Åke , Staaf Johan , Rydén Lisa
Published: April 2023

Principal clinicopathological and gene expression features for each predictor type and evaluation group
Figure S7 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
Authors: Del Papa Beatrice , Baldoni Stefano , Dorillo Erica , De Falco Filomena , Rompietti Chiara , Cecchini Debora , Cantelmi Maria Grazia , Sorcini Daniele , Nogarotto Manuel , Adamo Francesco Maria , Mezzasoma Federica , Silva Barcelos Estevão Carlos , Albi Elisa , Iacucci Ostini Roberta , Di Tommaso Ambra , Marra Andrea , Montanaro Guido , Martelli Maria Paola , Falzetti Franca , Di Ianni Mauro , Rosati Emanuela , Sportoletti Paolo
Published: April 2023

Figure S7
Table S1 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort
Authors: Dihge Looket , Vallon-Christersson Johan , Hegardt Cecilia , Saal Lao H. , Häkkinen Jari , Larsson Christer , Ehinger Anna , Loman Niklas , Malmberg Martin , Bendahl Pär-Ola , Borg Åke , Staaf Johan , Rydén Lisa
Published: April 2023

Supplementary information on gene expression profiling ID and nodal status in the development and validation cohorts and distribution of clinicopathological characteristics
Supplementary Data from Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma
Authors: Thakur Rohit , Laye Jonathan P. , Lauss Martin , Diaz Joey Mark S. , O'Shea Sally Jane , Poźniak Joanna , Filia Anastasia , Harland Mark , Gascoyne Joanne , Randerson-Moor Juliette A. , Chan May , Mell Tracey , Jönsson Göran , Bishop D. Timothy , Newton-Bishop Julia , Barrett Jennifer H. , Nsengimana Jérémie
Published: April 2023

Supplementary Methods
Supplementary Data from Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks
Authors: Sundaravel Sriram , Kuo Wen-Liang , Jeong Jong Jin , Choudhary Gaurav S. , Gordon-Mitchell Shanisha , Liu Hui , Bhagat Tushar D. , McGraw Kathy L. , Gurbuxani Sandeep , List Alan F. , Verma Amit , Wickrema Amittha
Published: April 2023

Supplemental figure 1: A) Flow cytometry plots showing the levels of CD34 and CD90 following isolation of HSCs. B) Quantitation of percentages of CD34 and CD90 in HSCs. Data are mean {plus minus}SEM from three biological replicates. C) Photomicrograph of HSCs stained with benzidinehematoxylin (Scale bar, 10μM).
Supplementary Data from A Novel Engineered Small Protein for Positron Emission Tomography Imaging of Human Programmed Death Ligand-1: Validation in Mouse Models and Human Cancer Tissues
Authors: Natarajan Arutselvan , Patel Chirag B. , Ramakrishnan Sindhuja , Panesar Paramjyot S. , Long Steven R. , Gambhir Sanjiv S.
Published: April 2023

Supplementary document with figures 1-5.
Supplementary Data from Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks
Authors: Sundaravel Sriram , Kuo Wen-Liang , Jeong Jong Jin , Choudhary Gaurav S. , Gordon-Mitchell Shanisha , Liu Hui , Bhagat Tushar D. , McGraw Kathy L. , Gurbuxani Sandeep , List Alan F. , Verma Amit , Wickrema Amittha
Published: April 2023

Supplemental figure 3: Twenty four hours post DOCK4 siRNA nucleofection into TF1 cells, A) Control and DOCK4 knockdown TF1 cells were subjected to in vitro transwel migration assay. Data are represented as mean {plus minus}SEM from two technical replicates (*P < 0.05; Student's t test). Representative data from two independent experiments are shown. B) Control and DOCK4 knocked down TF1 cells were stained for actin and analyzed by immunofluorescence microscopy. Cells which depicted spread morphology with bundled actin at the leading edges were marked by white arrows (Scale bar, 15μM). Individual cells at high magnification showing cell spreading and bundled F-actin when DOCK4 levels were reduced.
Supplementary Table from Long-Term Survival Analysis of Adjuvant Chemotherapy with or without Trastuzumab in Patients with T1, Node-Negative HER2-Positive Breast Cancer
Authors: He Xuexin , Ji Jiali , Tian Mei , Esteva Francisco J. , Hortobagyi Gabriel N. , Yeung Sai-Ching Jim
Published: April 2023

Supplementary table 1. Restricted mean survival time (RMST) analysis of overall survival in patients with pT1N0M0 HER2-positive breast cancer who received no adjuvant chemotherapy (group A) or adjuvant chemotherapy only (group B).
Supplementary Data from CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
Authors: Majzner Robbie G. , Theruvath Johanna L. , Nellan Anandani , Heitzeneder Sabine , Cui Yongzhi , Mount Christopher W. , Rietberg Skyler P. , Linde Miles H. , Xu Peng , Rota Christopher , Sotillo Elena , Labanieh Louai , Lee Daniel W. , Orentas Rimas J. , Dimitrov Dimiter S. , Zhu Zhongyu , Croix Brad St , Delaidelli Alberto , Sekunova Alla , Bonvini Ezio , Mitra Siddhartha S. , Quezado Martha M. , Majeti Ravindra , Monje Michelle , Sorensen Poul H.B. , Maris John M. , Mackall Crystal L.
Published: April 2023

Supplementary Figures
Supplementary Video S4 from Unexpected Activities in Regulating Ciliation Contribute to Off-target Effects of Targeted Drugs
Authors: Kiseleva Anna A. , Korobeynikov Vladislav A. , Nikonova Anna S. , Zhang Peishan , Makhov Petr , Deneka Alexander Y. , Einarson Margret B. , Serebriiskii Ilya G. , Liu Hanqing , Peterson Jeffrey R. , Golemis Erica A.
Published: April 2023

Supplementary Video S4. Time-lapse images of hTERT-RPE1-Arl13b-GFP cells starved in serum-free Opti-MEM for 48 hours, then incubated for 3 hours in 1 µM ganetespib.
Supplementary Video S2 from Unexpected Activities in Regulating Ciliation Contribute to Off-target Effects of Targeted Drugs
Authors: Kiseleva Anna A. , Korobeynikov Vladislav A. , Nikonova Anna S. , Zhang Peishan , Makhov Petr , Deneka Alexander Y. , Einarson Margret B. , Serebriiskii Ilya G. , Liu Hanqing , Peterson Jeffrey R. , Golemis Erica A.
Published: April 2023

Supplementary Video S2. Time-lapse images of hTERT-RPE1-Arl13b-GFP cells starved in serum-free Opti-MEM for 48 hours, then incubated for 3 hours in 20% FBS.
Supplementary Figure 4 from PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN
Authors: Flaifel Abdallah , Xie Wanling , Braun David A. , Ficial Miriam , Bakouny Ziad , Nassar Amin H. , Jennings Rebecca B. , Escudier Bernard , George Daniel J. , Motzer Robert J. , Morris Michael J. , Powles Thomas , Wang Evelyn , Huang Ying , Freeman Gordon J. , Choueiri Toni K. , Signoretti Sabina
Published: April 2023

Immune cell density by PD-L1 expression
Supplementary Data from Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma
Authors: Haas Naomi B. , Appleman Leonard J. , Stein Mark , Redlinger Maryann , Wilks Melissa , Xu Xiaowei , Onorati Angelique , Kalavacharla Anusha , Kim Taehyong , Zhen Chao Jie , Kadri Sabah , Segal Jeremy P. , Gimotty Phyllis A. , Davis Lisa E. , Amaravadi Ravi K.
Published: April 2023

Supplemental Figures 1 and 2 (S1. Measurement of autophagic vesicles in PBMC and S2 Massively parallel sequencing and outcome.
Supplementary Table S4 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
Authors: Sharifi Zeinab , Abdulkarim Bassam , Meehan Brian , Rak Janusz , Daniel Paul , Schmitt Julie , Lauzon Nidia , Eppert Kolja , Duncan Heather M. , Petrecca Kevin , Guiot Marie-Christine , Jean-Claude Bertrand , Sabri Siham
Published: April 2023

Table S4 summarizes the complete blood count (CBC) for ZR2002 continuous treatment (schedule #2).
Supplementary Table S3 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
Authors: Sharifi Zeinab , Abdulkarim Bassam , Meehan Brian , Rak Janusz , Daniel Paul , Schmitt Julie , Lauzon Nidia , Eppert Kolja , Duncan Heather M. , Petrecca Kevin , Guiot Marie-Christine , Jean-Claude Bertrand , Sabri Siham
Published: April 2023

Table S3 summarizes the complete blood count (CBC) and biochemistry assessment of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) enzymes for ZR2002 alternate treatment (schedule #1).
Supplementary Table S1 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
Authors: Sharifi Zeinab , Abdulkarim Bassam , Meehan Brian , Rak Janusz , Daniel Paul , Schmitt Julie , Lauzon Nidia , Eppert Kolja , Duncan Heather M. , Petrecca Kevin , Guiot Marie-Christine , Jean-Claude Bertrand , Sabri Siham
Published: April 2023

Table S1 summarizes molecular and genomic characteristics of GBM cell lines and GSCs.
Supplementary Data from Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma
Authors: Qin Yi , Wu Chung W. , Taylor William R. , Sawas Tarek , Burger Kelli N. , Mahoney Douglas W. , Sun Zhifu , Yab Tracy C. , Lidgard Graham P. , Allawi Hatim T. , Buttar Navtej S. , Smyrk Thomas C. , Iyer Prasad G. , Katzka David A. , Ahlquist David A. , Kisiel John B.
Published: April 2023

Supplemental Tables 1 and 2
Supplementary Figure 5 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
Authors: Sharifi Zeinab , Abdulkarim Bassam , Meehan Brian , Rak Janusz , Daniel Paul , Schmitt Julie , Lauzon Nidia , Eppert Kolja , Duncan Heather M. , Petrecca Kevin , Guiot Marie-Christine , Jean-Claude Bertrand , Sabri Siham
Published: April 2023

Figure S5 shows additional MALDI imaging mass spectrometry (MALDI IMS) data to confirm the presence of ZR2002 in brain tumor tissue.
Supplemental Data 2 from Coordinately Targeting Cell-Cycle Checkpoint Functions in Integrated Models of Pancreatic Cancer
Authors: Chung Sejin , Vail Paris , Witkiewicz Agnieszka K. , Knudsen Erik S.
Published: April 2023

Full list of agents used in drug screen described in Figure 4.
Supplementary Table from PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors
Authors: Tateishi Kensuke , Nakamura Taishi , Juratli Tareq A. , Williams Erik A. , Matsushita Yuko , Miyake Shigeta , Nishi Mayuko , Miller Julie J. , Tummala Shilpa S. , Fink Alexandria L. , Lelic Nina , Koerner Mara V.A. , Miyake Yohei , Sasame Jo , Fujimoto Kenji , Tanaka Takahiro , Minamimoto Ryogo , Matsunaga Shigeo , Mukaihara Shigeo , Shuto Takashi , Taguchi Hiroki , Udaka Naoko , Murata Hidetoshi , Ryo Akihide , Yamanaka Shoji , Curry William T. , Dias-Santagata Dora , Yamamoto Tetsuya , Ichimura Koichi , Batchelor Tracy T. , Chi Andrew S. , Iafrate A. John , Wakimoto Hiroaki , Cahill Daniel P.
Published: April 2023

Supplementary Table 1 Primers used for PCR amplification and sequencing Supplementary Table 2 Results of Multiplex PCR based MGH SNAPShot assay, Pyrosequencing and Sanger sequencing in YMG6 patient and xenograft cells Supplementary Table 3 Analysis of microsatellite instability in YMG6 parent and xenograft tumors Supplementary Table 4 Quantitative analysis for MGMT methylation status in YMG6 cells Supplementary Table 5 Multiplex PCR based MGH SnaPShot assay for oligodendroglial tumors Supplementary Table 6 Correlation of xenograft lethality and phosphorylation of PI3K pathway protein Supplementary Table 7 Phosphorylation in PI3K pathway in oligodendroglioma xenograft model Supplementary Table 8 Clinical characteristics in oligodendroglial tumor patients
Figure S7 from The Ewing Family of Tumors Relies on BCL-2 and BCL-XL to Escape PARP Inhibitor Toxicity
Authors: Heisey Daniel A.R. , Lochmann Timothy L. , Floros Konstantinos V. , Coon Colin M. , Powell Krista M. , Jacob Sheeba , Calbert Marissa L. , Ghotra Maninderjit S. , Stein Giovanna T. , Maves Yuki Kato , Smith Steven C. , Benes Cyril H. , Leverson Joel D. , Souers Andrew J. , Boikos Sosipatros A. , Faber Anthony C.
Published: April 2023

EWS-FLI1 increases BCL-2 expression in EWFT.
Figure S2 from The Ewing Family of Tumors Relies on BCL-2 and BCL-XL to Escape PARP Inhibitor Toxicity
Authors: Heisey Daniel A.R. , Lochmann Timothy L. , Floros Konstantinos V. , Coon Colin M. , Powell Krista M. , Jacob Sheeba , Calbert Marissa L. , Ghotra Maninderjit S. , Stein Giovanna T. , Maves Yuki Kato , Smith Steven C. , Benes Cyril H. , Leverson Joel D. , Souers Andrew J. , Boikos Sosipatros A. , Faber Anthony C.
Published: April 2023

A chemotherapy naive and chemotherapy resistant cell line pair respond differently to olaparib.
Supplementary Data from Molecular Profiling of Cohorts of Tumor Samples to Guide Clinical Development of Pembrolizumab as Monotherapy
Authors: Ayers Mark , Nebozhyn Michael , Cristescu Razvan , McClanahan Terrill K. , Perini Rodolfo , Rubin Eric , Cheng Jonathan D. , Kaufman David R. , Loboda Andrey
Published: April 2023

Supplementary Tables S1, S2; Supplementary Figures S1, S2, S3, S4
FIgure S6 from The Ewing Family of Tumors Relies on BCL-2 and BCL-XL to Escape PARP Inhibitor Toxicity
Authors: Heisey Daniel A.R. , Lochmann Timothy L. , Floros Konstantinos V. , Coon Colin M. , Powell Krista M. , Jacob Sheeba , Calbert Marissa L. , Ghotra Maninderjit S. , Stein Giovanna T. , Maves Yuki Kato , Smith Steven C. , Benes Cyril H. , Leverson Joel D. , Souers Andrew J. , Boikos Sosipatros A. , Faber Anthony C.
Published: April 2023

Olaparib sensitivity is modulated by BCL2 family expression
Figure S4 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
Authors: Carbajosa Sofía , Pansa María Florencia , Paviolo Natalia S. , Castellaro Andrés M. , Andino Diego L. , Nigra Ayelén D. , García Iris Alejandra , Racca Ana C. , Rodriguez-Berdini Lucía , Angiolini Virginia , Guantay Laura , Villafañez Florencia , Federico María Belén , Rodríguez-Baili María Celeste , Caputto Beatriz L. , Drewes Gerard , Madauss Kevin P. , Gloger Israel , Fernandez Elmer , Gil Germán A. , Bocco José Luis , Gottifredi Vanesa , Soria Gastón
Published: April 2023

Legends included in the figure file
Supplementary materials from Tissue 2-Hydroxyglutarate as a Biomarker for Isocitrate Dehydrogenase Mutations in Gliomas
Authors: Sim Hao-Wen , Nejad Romina , Zhang Wenjiang , Nassiri Farshad , Mason Warren , Aldape Kenneth D. , Zadeh Gelareh , Chen Eric X.
Published: April 2023

supplementary Figure 1, Tables 1-3 Figure 1. Representative chromatograms from IDH wild type and IDH mutant glioma samples Table 1. Individual R- and S-2-HG concentrations in all patients Table 2. Individual R- and S-2-HG concentrations from patient samples obtained in real-time. Table 3. Inter- and intra-assay accuracy and precision
Supplementary Data from Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer
Authors: Lazzari Luca , Corti Giorgio , Picco Gabriele , Isella Claudio , Montone Monica , Arcella Pamela , Durinikova Erika , Zanella Eugenia R. , Novara Luca , Barbosa Fabiane , Cassingena Andrea , Cancelliere Carlotta , Medico Enzo , Sartore-Bianchi Andrea , Siena Salvatore , Garnett Mathew J. , Bertotti Andrea , Trusolino Livio , Di Nicolantonio Federica , Linnebacher Michael , Bardelli Alberto , Arena Sabrina
Published: April 2023

Supplementary Legends and Figures
Supplementary Data from VEGFR1+ Metastasis–Associated Macrophages Contribute to Metastatic Angiogenesis and Influence Colorectal Cancer Patient Outcome
Authors: Freire Valls Aida , Knipper Karl , Giannakouri Evangelia , Sarachaga Víctor , Hinterkopf Sascha , Wuehrl Michael , Shen Ying , Radhakrishnan Praveenkumar , Klose Johannes , Ulrich Alexis , Schneider Martin , Augustin Hellmut G. , Ruiz de Almodovar Carmen , Schmidt Thomas
Published: April 2023

Supplementary methods, tables and supplementary figure legends Table S1. Patient characteristics. Table S2. Kind of neo-adjuvant therapy from LM patients included in the analysis of blood samples by flow cytometry. Table S3. Primer list used for qRT-PCR. Table S4. Association of circulating CD11b+ CD68+ VEGFR1+ cells with clinicopathologic variables in patients with liver metastasis of colorectal cancer. Table S5. Univariate analysis of factors associated with progression-free survival in patients with liver metastasis of CRC. Table S6. Multivariate analysis of factors associated with circulating VEGFR1+ macrophages and progression-free survival in LM patients.
Supplementary Tables and Figures from Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients
Authors: Drennan Samantha , Chiodin Giorgia , D'Avola Annalisa , Tracy Ian , Johnson Peter W. , Trentin Livio , Steele Andrew J. , Packham Graham , Stevenson Freda K. , Forconi Francesco
Published: April 2023

Supplementary Tables S1-S2 and Figures S1-S4 with legends
Supplementary Table 2 from Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas
Authors: Capdevila Jaume , Arqués Oriol , Hernández Mora Jose Ramón , Matito Judit , Caratù Ginevra , Mancuso Francesco M. , Landolfi Stefania , Barriuso Jorge , Jimenez-Fonseca Paula , Lopez Lopez Carlos , Garcia-Carbonero Rocio , Hernando Jorge , Matos Ignacio , Paolo Nuciforo , Hernández-Losa Javier , Esteller Manel , Martínez-Cardús Anna , Tabernero Josep , Vivancos Ana , Palmer Héctor G.
Published: April 2023

Supplementary Table 2
Supplementary Figure Legends from Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas
Authors: Capdevila Jaume , Arqués Oriol , Hernández Mora Jose Ramón , Matito Judit , Caratù Ginevra , Mancuso Francesco M. , Landolfi Stefania , Barriuso Jorge , Jimenez-Fonseca Paula , Lopez Lopez Carlos , Garcia-Carbonero Rocio , Hernando Jorge , Matos Ignacio , Paolo Nuciforo , Hernández-Losa Javier , Esteller Manel , Martínez-Cardús Anna , Tabernero Josep , Vivancos Ana , Palmer Héctor G.
Published: April 2023

Supplementary Figure Legends
Supplementary Figure 1 from Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas
Authors: Capdevila Jaume , Arqués Oriol , Hernández Mora Jose Ramón , Matito Judit , Caratù Ginevra , Mancuso Francesco M. , Landolfi Stefania , Barriuso Jorge , Jimenez-Fonseca Paula , Lopez Lopez Carlos , Garcia-Carbonero Rocio , Hernando Jorge , Matos Ignacio , Paolo Nuciforo , Hernández-Losa Javier , Esteller Manel , Martínez-Cardús Anna , Tabernero Josep , Vivancos Ana , Palmer Héctor G.
Published: April 2023

Supplementary Figure 1
Supplementary Table S3 from IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
Authors: Conlon Kevin C. , Potter E. Lake , Pittaluga Stefania , Lee Chyi-Chia Richard , Miljkovic Milos D. , Fleisher Thomas A. , Dubois Sigrid , Bryant Bonita R. , Petrus Michael , Perera Liyanage P. , Hsu Jennifer , Figg William D. , Peer Cody J. , Shih Joanna H. , Yovandich Jason L. , Creekmore Stephen P. , Roederer Mario , Waldmann Thomas A.
Published: April 2023

Supplementary Table S3
Supplementary Data from Serum Nardilysin, a Surrogate Marker for Epithelial–Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical Resection
Authors: Yoh Tomoaki , Hatano Etsuro , Kasai Yosuke , Fuji Hiroaki , Nishi Kiyoto , Toriguchi Kan , Sueoka Hideaki , Ohno Mikiko , Seo Satoru , Iwaisako Keiko , Taura Kojiro , Yamaguchi Rina , Kurokawa Masato , Fujimoto Jiro , Kimura Takeshi , Uemoto Shinji , Nishi Eiichiro
Published: April 2023

Supplementary Tables S1-S7; Supplementary Figures S1-S7
Supplementary Data from IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
Authors: Conlon Kevin C. , Potter E. Lake , Pittaluga Stefania , Lee Chyi-Chia Richard , Miljkovic Milos D. , Fleisher Thomas A. , Dubois Sigrid , Bryant Bonita R. , Petrus Michael , Perera Liyanage P. , Hsu Jennifer , Figg William D. , Peer Cody J. , Shih Joanna H. , Yovandich Jason L. , Creekmore Stephen P. , Roederer Mario , Waldmann Thomas A.
Published: April 2023

Supplementary Data (Tracking)
Figure S4 from IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
Authors: Conlon Kevin C. , Potter E. Lake , Pittaluga Stefania , Lee Chyi-Chia Richard , Miljkovic Milos D. , Fleisher Thomas A. , Dubois Sigrid , Bryant Bonita R. , Petrus Michael , Perera Liyanage P. , Hsu Jennifer , Figg William D. , Peer Cody J. , Shih Joanna H. , Yovandich Jason L. , Creekmore Stephen P. , Roederer Mario , Waldmann Thomas A.
Published: April 2023

Supplementary Figure S4
Figure S2 from IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
Authors: Conlon Kevin C. , Potter E. Lake , Pittaluga Stefania , Lee Chyi-Chia Richard , Miljkovic Milos D. , Fleisher Thomas A. , Dubois Sigrid , Bryant Bonita R. , Petrus Michael , Perera Liyanage P. , Hsu Jennifer , Figg William D. , Peer Cody J. , Shih Joanna H. , Yovandich Jason L. , Creekmore Stephen P. , Roederer Mario , Waldmann Thomas A.
Published: April 2023

Supplementary Figure S2
Supplementary Methods from Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer
Authors: Rashid Naim U. , Peng Xianlu L. , Jin Chong , Moffitt Richard A. , Volmar Keith E. , Belt Brian A. , Panni Roheena Z. , Nywening Timothy M. , Herrera Silvia G. , Moore Kristin J. , Hennessey Sarah G. , Morrison Ashley B. , Kawalerski Ryan , Nayyar Apoorve , Chang Audrey E. , Schmidt Benjamin , Kim Hong Jin , Linehan David C. , Yeh Jen Jen
Published: April 2023

Supplementary Methods
Figure S1 from IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
Authors: Conlon Kevin C. , Potter E. Lake , Pittaluga Stefania , Lee Chyi-Chia Richard , Miljkovic Milos D. , Fleisher Thomas A. , Dubois Sigrid , Bryant Bonita R. , Petrus Michael , Perera Liyanage P. , Hsu Jennifer , Figg William D. , Peer Cody J. , Shih Joanna H. , Yovandich Jason L. , Creekmore Stephen P. , Roederer Mario , Waldmann Thomas A.
Published: April 2023

Supplementary Figure S1
Table S1 from BRCA1 Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated miR-155 to Disrupt Myeloid Differentiation in Myeloid Malignancies
Authors: Poh Weijie , Dilley Robert L. , Moliterno Alison R. , Maciejewski Jaroslaw P. , Pratz Keith W. , McDevitt Michael A. , Herman James G.
Published: April 2023

Table S1 shows the primer sequences used for qMSP, MSP, RT-qPCR
Supplementary Data #3 from Genomic Profiling Identifies Association of IDH1/IDH2 Mutation with Longer Relapse-Free and Metastasis-Free Survival in High-Grade Chondrosarcoma
Authors: Zhu Guo Gord , Nafa Khedoudja , Agaram Narasimhan , Zehir Ahmet , Benayed Ryma , Sadowska Justyna , Borsu Laetitia , Kelly Ciara , Tap William D. , Fabbri Nicola , Athanasian Edward , Boland Patrick J. , Healey John H. , Berger Michael F. , Ladanyi Marc , Hameed Meera
Published: April 2023

CHS Mutations and CNA
Supplementary Data from Cancer-associated Fibroblast–promoted LncRNA DNM3OS Confers Radioresistance by Regulating DNA Damage Response in Esophageal Squamous Cell Carcinoma
Authors: Zhang Hongfang , Hua Yuhui , Jiang Zhenzhen , Yue Jing , Shi Ming , Zhen Xiaoli , Zhang Xiaoyan , Yang Ling , Zhou Rongjing , Wu Shixiu
Published: April 2023

Supplementary Figure. S3. Inhibition of DNM3OS expression improved the radiosensitivity of KYSE-150R xenograft tumors.
Supplementary Data from Cancer-associated Fibroblast–promoted LncRNA DNM3OS Confers Radioresistance by Regulating DNA Damage Response in Esophageal Squamous Cell Carcinoma
Authors: Zhang Hongfang , Hua Yuhui , Jiang Zhenzhen , Yue Jing , Shi Ming , Zhen Xiaoli , Zhang Xiaoyan , Yang Ling , Zhou Rongjing , Wu Shixiu
Published: April 2023

Supplementary Figure. S4 DNM3OS inhibited irradiation-induced DNA damage in esophageal cancer cells by immunofluorescence analysis.
Supplementary Data from Cancer-associated Fibroblast–promoted LncRNA DNM3OS Confers Radioresistance by Regulating DNA Damage Response in Esophageal Squamous Cell Carcinoma
Authors: Zhang Hongfang , Hua Yuhui , Jiang Zhenzhen , Yue Jing , Shi Ming , Zhen Xiaoli , Zhang Xiaoyan , Yang Ling , Zhou Rongjing , Wu Shixiu
Published: April 2023

Supplementary Figure. S6. DNM3OS regulated DNA damage response in KYSE-150R cells.
Figure S6 from Depression-Induced Neuropeptide Y Secretion Promotes Prostate Cancer Growth by Recruiting Myeloid Cells
Authors: Cheng Yan , Tang Xin-Ying , Li Yi-Xuan , Zhao Dan-Dan , Cao Qiu-Hua , Wu Hong-Xi , Yang Hong-Bao , Hao Kun , Yang Yong
Published: April 2023

Schematic plot for cell culture assay.
Figure S3 from Depression-Induced Neuropeptide Y Secretion Promotes Prostate Cancer Growth by Recruiting Myeloid Cells
Authors: Cheng Yan , Tang Xin-Ying , Li Yi-Xuan , Zhao Dan-Dan , Cao Qiu-Hua , Wu Hong-Xi , Yang Hong-Bao , Hao Kun , Yang Yong
Published: April 2023

Gating strategy for bone marrow, spleen and peripheral blood myeloid cell analysis by flow cytometry.
Table S3 from BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer
Authors: Walsh Louise , Haley Kathryn E. , Moran Bruce , Mooney Brian , Tarrant Finbarr , Madden Stephen F. , Di Grande Alessandra , Fan Yue , Das Sudipto , Rueda Oscar M. , Dowling Catríona M. , Varešlija Damir , Chin Suet-Feung , Linn Sabine , Young Leonie S. , Jirström Karin , Crown John P. , Bernards Rene , Caldas Carlos , Gallagher William M. , O'Connor Darran P. , Ní Chonghaile Tríona
Published: April 2023

Table S3: Cox regression analysis on RATHER RNA-seq data
Supplementary Data Legends from Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218
Authors: Alvarez Secord Angeles , Bell Burdett Kirsten , Owzar Kouros , Tritchler David , Sibley Alexander B. , Liu Yingmiao , Starr Mark D. , Brady J. Chris , Lankes Heather A. , Hurwitz Herbert I. , Mannel Robert S. , Tewari Krishnansu S. , O'Malley David M. , Gray Heidi , Bakkum-Gamez Jamie N. , Fujiwara Keiichi , Boente Matthew , Deng Wei , Burger Robert A. , Birrer Michael J. , Nixon Andrew B.
Published: April 2023

Legends
Figure S5 from Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218
Authors: Alvarez Secord Angeles , Bell Burdett Kirsten , Owzar Kouros , Tritchler David , Sibley Alexander B. , Liu Yingmiao , Starr Mark D. , Brady J. Chris , Lankes Heather A. , Hurwitz Herbert I. , Mannel Robert S. , Tewari Krishnansu S. , O'Malley David M. , Gray Heidi , Bakkum-Gamez Jamie N. , Fujiwara Keiichi , Boente Matthew , Deng Wei , Burger Robert A. , Birrer Michael J. , Nixon Andrew B.
Published: April 2023

Relationship between covariates and IL6.